April 15, 2025
Internationally recognized clinician brings over 35 years of interventional pain management expertise and industry leadership.
News Archive
March 17, 2025
New NeoCast Publication in Advanced Healthcare Materials
February 19, 2025
ResQFoam Publication in Trauma Surgery and Acute Care Open
February 6, 2025
EMBO-02 Assesses NeoCast™ for the Treatment of Chronic Subdural Hematoma
February 5, 2025
Next-Generation Liquid Embolic, NeoCast™, Successfully Occludes Distal Middle Meningeal Artery
Branches of Chronic Subdural Hematoma Patients in Initial Cohort of First-In-Human Study
Branches of Chronic Subdural Hematoma Patients in Initial Cohort of First-In-Human Study
November 14, 2024
Arsenal Medical Launches EMBO-02 Study for NeoCast™ to Assess Treatment of Chronic Subdural Hematoma
First Patient Enrolled in Trial to Evaluate Safety and Feasibility of Innovative Embolic Agent in Expanded Patient Population Utilizing Middle Meningeal Artery Embolization (MMAe)
July 24, 2024
Data show NeoCast™ met primary endpoints and enabled significant distal penetration of hypervascular brain tumors
July 22, 2024
NeoCast occluded approximately five times more vessel branches compared to the market-leading liquid embolic agent in swine kidneys
October 18, 2023
Medgadget
Interview with Upma Sharma, President and CEO of Arsenal Medical
July 26, 2023
Successful deployment of Arsenal's investigational first-in-class, embolic biomaterial for neurovascular conditions